Back

Use and costs of P2Y12 inhibitors after myocardial infarction in germany and the US

31 August 2026 (12:15 - 12:40)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes: local deposition vs. systemic treatment Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Fabian Mueller

Munich (Germany)

1 More presentation in this session

Presentation thumbnail
One-year clinical outcomes of aspirin versus indobufen in patients with NSTEMI: a multicenter retrospective cohort study
Doctor H. Zhang (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes: local deposition vs. systemic treatment

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry
30 August 2025
thumbnail
Congress Presentation
Utilization patterns of potent GLP-1-RA among patients with type 2 diabetes in clinical practice
31 August 2026
thumbnail
Congress Presentation
Cost analysis of microaxial flow pump (Impella) versus standard care in cardiogenic shock: findings from the danger shock trial
31 August 2026
thumbnail
Congress Presentation
The first year of generic NOACs: implications for patients and the healthcare system
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources